Appropriate and Inappropriate Use of Vitamin D₃ Testing: Evidence, Indications, and Health System Implications: A narrative review

Authors

DOI:

https://doi.org/10.64554/nujms.2026.2.2.3

Keywords:

vitamin D; 25-hydroxyvitamin D; screening; diagnostic stewardship; low-value care; narrative review; Iraq

Abstract

Background: Vitamin D is required for calcium and phosphate homeostasis. Severe deficiency causes rickets in children and osteomalacia in adults .Objective: Requests for serum vitamin D tests have increased sharply in many health systems, although guidelines do not support screening adults without symptoms or risk factors. This review examines when measuring 25-hydroxyvitamin D changes patient management and how unnecessary testing can be reduced, with attention to Iraq and the Middle East. Methods: A narrative review of guidelines, randomized trials, systematic reviews, studies of test utilization and de-implementation, identified through PubMed and guideline and journal websites (last search 13 October 2026) and summarized qualitatively. Results: No guideline recommends screening the general adult population, and current guidance supports supplementing groups such as adults aged 75 years or older and pregnant women without prior testing. Testing remains useful when osteomalacia, malabsorption, chronic kidney disease, or a mineral disorder is suspected. Large trials in unselected adults showed no reduction in cancer, cardiovascular events, fractures, or death, and a test-and-treat trial did not prevent respiratory infection. Differences in thresholds, assays, season, and acute illness complicate interpretation. Electronic alerts, requisition forms, and coverage rules reduced testing by 8% to 91%, but rarely measured patient outcomes. Iraqi data come from laboratory-referred samples and cannot show how often testing is inappropriate. Conclusions: Vitamin D should be measured to answer a defined clinical question. Iraqi services should audit indications and repeat testing, agree on local criteria, and monitor missed deficiency.

Downloads

Download data is not yet available.

References

1. Christakos S, Dhawan P, Verstuyf A, et al. Vitamin D: metabolism, molecular mechanism of action, pleiotropic effects. Physiol Rev. 2016;96(1):365-408. https://doi.org/10.1152/physrev.00014.2015.

2. US Preventive Services Task Force; Krist AH, Davidson KW, Mangione CM, et al. Screening for vitamin D deficiency in adults: US Preventive Services Task Force recommendation statement. JAMA. 2021;325(14):1436-1442. https://doi.org/10.1001/jama.2021.3069.

3. Kahwati LC, LeBlanc E, Weber RP, et al. Screening for vitamin D deficiency in adults: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2021;325(14):1443-1463. https://doi.org/10.1001/jama.2020.26498.

4. Sempos CT, Heijboer AC, Bikle DD, et al. Vitamin D assays and the definition of hypovitaminosis D: results from the First International Conference on Controversies in Vitamin D. Br J Clin Pharmacol. 2018;84(10):2194-2207. https://doi.org/10.1111/bcp.13652.

5. Autier P, Boniol M, Pizot C, et al. Vitamin D status and ill health: a systematic review. Lancet Diabetes Endocrinol. 2014;2(1):76-89. https://doi.org/10.1016/S2213-8587(13)70165-7.

6. Breth-Petersen M, Bell K, Pickles K, et al. Health, financial and environmental impacts of unnecessary vitamin D testing: a triple bottom line assessment adapted for healthcare. BMJ Open. 2022;12(8):e056997. https://doi.org/10.1136/bmjopen-2021-056997.

7. Zemp J, Erol C, Kaiser E, et al. A systematic review of evidence-based clinical guidelines for vitamin D screening and supplementation over the last decade. Arch Public Health. 2025;83(1):221. https://doi.org/10.1186/s13690-025-01709-x.

8. Ross AC, Manson JE, Abrams SA, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011;96(1):53-58. https://doi.org/10.1210/jc.2010-2704.

9. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911-1930. https://doi.org/10.1210/jc.2011-0385.

10. Demay MB, Pittas AG, Bikle DD, et al. Vitamin D for the prevention of disease: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2024;109(8):19071947. https://doi.org/10.1210/clinem/dgae290.

11. Cashman KD, Dowling KG, Škrabáková Z, et al. Vitamin D deficiency in Europe: pandemic? Am J Clin Nutr. 2016;103(4):1033-1044. https://doi.org/10.3945/ajcn.115.120873.

12. Carter GD, Berry J, Durazo-Arvizu R, et al. Hydroxyvitamin D assays: an historical perspective from DEQAS. J Steroid Biochem Mol Biol. 2018;177:30-35. https://doi.org/10.1016/j.jsbmb.2017.07.018.

13. Antonelli MJ, Kushner I, Epstein M. The constellation of vitamin D, the acute-phase response, inflammation. Cleve Clin J Med. 2023;90(2):85-89. https://doi.org/10.3949/ccjm.90a.22048.

14. Murphy J, Kang Y, Turner PJ, et al. Diagnostic accuracy of point-of-care tests to diagnose vitamin D deficiency in adults and children: systematic review. Diagnostics (Basel). 2026;16(8):1129. https://doi.org/10.3390/diagnostics16081129.

15. Aspray TJ, Bowring C, Fraser W, et al. National Osteoporosis Society vitamin D guideline summary. Age Ageing. 2014;43(5):592-595. https://doi.org/10.1093/ageing/afu093.

16. National Institute for Health and Care Excellence. Vitamin D: supplement use in specific population groups. Public health guideline PH56. London: NICE; 2014 (updated 2017 Aug 30) [cited 2026 Oct 13]. Available from: https://www.nice.org.uk/guidance/ph56.

17. College of Family Physicians of Canada. Family medicine: fifteen tests and treatments to question. Recommendation 13: vitamin D testing in low-risk adults. Toronto: Choosing Wisely Canada; updated 2026 Feb [cited 2026 Oct 13]. Available from: https://choosingwiselycanada.org/recommendation/family-medicine/

18. Royal Osteoporosis Society. Vitamin D and bone health: a practical clinical guideline for patient management. Version 2. Camerton: Royal Osteoporosis Society; 2020 [cited 2026 Oct 13]. Available from: https://www.hiowformulary.nhs.uk/docs/files/ros-vitamin-d-and-bonehealth-in-adults-february-2020.pdf

19. Royal College of Pathologists of Australasia. Use and interpretation of vitamin D testing. Guideline 1/2013. Surry Hills: RCPA; 2013 (updated 2023 Dec) [cited 2026 Oct 13]. Available from: https://www.rcpa.edu.au/getattachment/ce168865-21ec-4981-b389-b2cb0618fc2b/Useand-Interpretation-of-Vitamin-D-Testing.aspx.

20. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl (2011). 2017;7(1):1-59. https://doi.org/10.1016/j.kisu.2017.04.001.

21. Giustina A, Bilezikian JP, Adler RA, et al. Consensus statement on vitamin D status assessment and supplementation: whys, whens, and hows. Endocr Rev. 2024;45(5):625-654. https://doi.org/10.1210/endrev/bnae009.

22. Lim K, Thadhani R. Vitamin D toxicity. J Bras Nefrol. 2020;42(2):238-244. https://doi.org/10.1590/2175-8239-JBN-2019-0192.

23. Autier P, Mullie P, Macacu A, et al. Effect of vitamin D supplementation on non-skeletal disorders: a systematic review of meta-analyses and randomised trials. Lancet Diabetes Endocrinol. 2017;5(12):986-1004. https://doi.org/10.1016/S2213-8587(17)30357-1.

24. Manson JE, Cook NR, Lee IM, et al. Vitamin D supplements and prevention of cancer and cardiovascular disease. N https://doi.org/10.1056/NEJMoa1809944.

25. LeBoff MS, Chou SH, Ratliff KA, et al. Supplemental vitamin D and incident fractures in midlife adults. N Engl J Med. 2022;387(4):299-309. https://doi.org/10.1056/NEJMoa2202106.

26. Neale RE, Baxter C, Romero BD, et al. The D-Health Trial: a randomised controlled trial of the effect of vitamin D on mortality. Lancet Diabetes Endocrinol. 2022;10(2):120-128. https://doi.org/10.1016/S2213-8587(21)00345-4.

27. Thompson B, Waterhouse M, English DR, et al. Vitamin D supplementation and major cardiovascular events: D-Health randomised controlled trial. BMJ. 2023;381:e075230. https://doi.org/10.1136/bmj-2023-075230.

28. Pittas AG, Kawahara T, Jorde R, et al. Vitamin D and risk for type 2 diabetes in people with prediabetes: a systematic review and meta-analysis of individual participant data from 3 randomized clinical trials. Ann Intern Med. 2023;176(3):355-363. https://doi.org/10.7326/M22-3018.

29. Jolliffe DA, Holt H, Greenig M, et al. Effect of a test-and-treat approach to vitamin D supplementation on risk of all cause acute respiratory tract infection and covid-19: phase 3 randomised controlled trial (CORONAVIT). BMJ. 2022;378:e071230. https://doi.org/10.1136/bmj-2022-071230.

30. Jolliffe DA, Camargo CA Jr, Sluyter JD, et al. Vitamin D supplementation to prevent acute respiratory infections: systematic review and meta-analysis of stratified aggregate data. Lancet Diabetes Endocrinol. 2025;13(4):307-320. https://doi.org/10.1016/S2213-8587(24)00348-6.

31. Crowe FL, Jolly K, MacArthur C, et al. Trends in the incidence of testing for vitamin D deficiency in primary care in the UK: a retrospective analysis of The Health Improvement Network (THIN), 2005-2015. BMJ Open. 2019;9(6):e028355. https://doi.org/10.1136/bmjopen-2018-028355.

32. Perales-Afán JJ, Aparicio-Pelaz D, Puente-Lanzarote JJ, et al. The impact of demand management on vitamin D testing. Biochem Med (Zagreb). 2025;35(2):020707. https://doi.org/10.11613/BM.2025.020707.

33. Bolland MJ, Kyle C, Grey A. Repeated measurements of vitamin D: common and very unlikely to indicate deficiency. Clin Endocrinol (Oxf). 2026;105(3):298-306. https://doi.org/10.1111/cen.70145.

34. Silverstein WK, Rangrej J, Malikov K, et al. Long-term changes in serum vitamin D testing after implementation of criteria-based testing. JAMA Intern Med. 2025;185(7):888-890. https://doi.org/10.1001/jamainternmed.2025.1000.

35. Kotta S, Gadhvi D, Jakeways N, et al. "Test me and treat me": attitudes to vitamin D deficiency and supplementation: a qualitative study. BMJ Open. 2015;5(7):e007401. https://doi.org/10.1136/bmjopen-2014-007401.

36. Hofstede H, van der Burg HAM, Mulder BC, et al. Reducing unnecessary vitamin testing in general practice: barriers and facilitators according to general practitioners and patients. BMJ Open. 2019;9(10):e029760. https://doi.org/10.1136/bmjopen-2019-029760.

37. Felcher AH, Gold R, Mosen DM, et al. Decrease in unnecessary vitamin D testing using clinical decision support tools: making it harder to do the wrong thing. J Am Med Inform Assoc. 2017;24(4):776-780. https://doi.org/10.1093/jamia/ocw182.

38. Hughes C, Myers MA, Tickell-Painter M, et al. Reducing inappropriate vitamin D testing: an analysis of three sequential diagnostic stewardship interventions and the carbon footprint implications. Clin Biochem. 2026;141:111060. https://doi.org/10.1016/j.clinbiochem.2025.111060.

39. Moynihan R, Doust J, Henry D. Preventing overdiagnosis: how to stop harming the healthy. BMJ. 2012;344:e3502. https://doi.org/10.1136/bmj.e3502.

40. Taylor PN, Davies JS. A review of the growing risk of vitamin D toxicity from inappropriate practice. Br J Clin Pharmacol. 2018;84(6):1121-1127. https://doi.org/10.1111/bcp.13573.

41. Hendrickson CD, McLemore MF, Dahir KM, et al. Is the climb worth the view? The savings/alert ratio for reducing vitamin D testing. Appl Clin Inform. 2020;11(1):160-165. https://doi.org/10.1055/s-0040-1701678.

42. Norton WE, Chambers DA. Unpacking the complexities of de-implementing inappropriate health interventions. Implement Sci. 2020;15(1):2. https://doi.org/10.1186/s13012-019-0960-9

43. Colla CH, Mainor AJ, Hargreaves C, et al. Interventions aimed at reducing use of low-value health services: a systematic review. Med Care Res Rev. 2017;74(5):507-550. https://doi.org/10.1177/1077558716656970.

44. Naugler C, Hemmelgarn B, Quan H, et al. Implementation of an intervention to reduce population-based screening for vitamin D deficiency: a cross-sectional study. CMAJ Open. 2017;5(1):E36-E39. https://doi.org/10.9778/cmajo.20160073.

45. Sallin A, Ammann D, Bähler C, et al. The impact of Choosing Wisely recommendations and insurance coverage restrictions on the provision of low-value care: an interrupted time series analysis of vitamin D tests. BMC Health Serv Res. 2025;25(1):1359. https://doi.org/10.1186/s12913-025-13524-9.

46. Hasan R, Downs S, Nakhleh R, et al. Curbing unnecessary vitamin D testing. NEJM Catal Innov Care Deliv. 2026;7(2):CAT.25.0237. https://doi.org/10.1056/CAT.25.0237.

47. Balsiger JK, Dettwiler R, Mooser B, et al. Comparison of two hospital quality improvement interventions on inappropriate measurement and supplementation of vitamin D: the WISE-D study. BMC Geriatr. 2026;26(1):421. https://doi.org/10.1186/s12877-026-07220-4.

48. Lips P, Cashman KD, Lamberg-Allardt C, et al. Current vitamin D status in European and Middle East countries and strategies to prevent vitamin D deficiency: a position statement of the European Calcified Tissue Society. Eur J Endocrinol. 2019;180(4):P23-P54. https://doi.org/10.1530/EJE-18-0736.

49. Haq A, Wimalawansa SJ, Pludowski P, et al. Clinical practice guidelines for vitamin D in the Emirates. J Steroid Biochem Mol Biol. 2018;175:4-11. https://doi.org/10.1016/j.jsbmb.2016.09.021.

50. Al Saleh Y, Beshyah SA, Hussein W, et al. Diagnosis and management of vitamin D deficiency in the Gulf Cooperative Council (GCC) countries: an expert consensus summary statement from the GCC vitamin D advisory board. Arch Osteoporos. 2020;15(1):35. https://doi.org/10.1007/s11657-020-0709-8.

51. World Health Organization Regional Office for the Eastern Mediterranean. Summary report on the consultation on the development of regional guidelines on vitamin D supplementation for the WHO Eastern Mediterranean Region, Beirut, Lebanon, 15-16 May 2023. Report No.: WHO-EM/NUT/313/E. Cairo: WHO Regional Office for the Eastern Mediterranean; 2024 [cited 2026 on Oct 13]. Available from: https://applications.emro.who.int/docs/WHOEMNUT313E-eng.pdf

52. Abdulrahman RM, Abdul Rahman BM. Prevalence of vitamin D level in the serum of patients living in Erbil city, Iraq, referred to private clinical laboratory and effect of age and sex it. J Biol Res (Boll Soc Ital Biol Sper). 2018;91(1):6916. https://doi.org/10.4081/jbr.2018.6916

53. Niven DJ, Mrklas KJ, Holodinsky JK, et al. Towards understanding the de-adoption of lowvalue practices: a scoping review. BMC Med. 2015;13:255. https://doi.org/10.1186/s12916-015-0488-z

54. Curran GM, Bauer M, Mittman B, et al. Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact. Med Care. 2012;50(3):217-226. https://doi.org/10.1097/MLR.0b013e3182408812.

Downloads

Published

2026-12-01

Issue

Section

Review Articles

How to Cite

Mustafa, H. A., Al-Bani, B. ., Ahmed Theyab, D. ., Zubair, O. A. ., & Shamoon, A. P. (2026). Appropriate and Inappropriate Use of Vitamin D₃ Testing: Evidence, Indications, and Health System Implications: A narrative review. Ninevah University Journal of Medical Sciences, 2(2), 22-32. https://doi.org/10.64554/nujms.2026.2.2.3